Short description
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Description
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
South San Francisco, California, United States, North America
Founded on
January 1, 1998
Exited on
April 29, 2004
Went public on
April 29, 2004
Stock symbol
CYTK
Non-profit?
No
Acquired?
No
Employees count
251-500
Revenue range
$7890 - 12340
Sign in for full access
Investors
Cannot Access, Noaccess, Uh Ohhhh, Absolutely Noaccess, Absolutely Noaccess, Noway Youcantaccess, Blurry Noaccess, No Way, Cannot Access, Noaccess, No Way
Sign in for full access
Founders
James Sabry, James Spudich, Lawrence Goldstein, Ronald Vale
Funding rounds count
2
Portfolio organisations count
Noaccess, Cannot Access
Sign in for full access
Lead investments count
2